Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHB2200071	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	Supplementary Application	2022-05-31		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2200072	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	Supplementary Application	2022-05-31		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2200076	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	Supplementary Application	2022-06-08		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHB2200077	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	Supplementary Application	2022-06-08		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHL2100136	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	New Drug Application	2021-02-25	百济神州（苏州）生物科技有限公司	Baiji Shenzhou (Suzhou) Biotechnology Co Ltd	In Review	2021-02-24	view
CXHL2100137	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	New Drug Application	2021-02-25	百济神州（苏州）生物科技有限公司	Baiji Shenzhou (Suzhou) Biotechnology Co Ltd	In Review	2021-02-24	view
CXHL2200291	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	New Drug Application	2022-05-10		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXHL2200296	苹果酸Sitravatinib胶囊	sitravatinib malate	Capsule	Chemical Drugs(1)	New Drug Application	2022-05-10		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view